TMS Solutions is Now Recruiting Patients for our Adolescent Depression FDA Clinical Study.

Study participants will receive no-cost NeuroStar TMS Therapy treatment.

Depressed.png

If you know a teen between the ages of 12-21 who is suffering from depression, they may be eligible to participate in a clinical study we are conducting, investigating NeuroStar TMS Therapy as a treatment that may help with adolescent depression.


The focus of this study is understanding the safety and effectiveness of NeuroStar TMS Therapy in adolescents suffering from Major Depressive Disorder (MDD). This study is currently enrolling participants who are:

  • Male or Female ages 12-21
  • Diagnosed with Major Depressive Disorder
  • Resistant to prior antidepressant medication
  • Experiencing depression lasting more than 4 weeks and less than 3 years

 

Click here to read more and for more information.

If you are in Western Colorado and interested in this adolescent depression study, please use the from below to sign up today. 

Topics: clinical trial